MedPath

Effect of Propofol-Dexmedetomidine on Cerebral Oxygenation and Metabolism During Brain Tumor Resection

Not Applicable
Completed
Conditions
Brain Tumor
Surgery
Interventions
Drug: Propofol-Dexmedetomidine group
Registration Number
NCT02575521
Lead Sponsor
Mansoura University
Brief Summary

Despite theoretical benefits of intravenous agents, volatile agents remain popular. In a study comparing desflurane, isoflurane, and sevoflurane in a porcine model of intracranial hypertension, at equipotent doses and normocapnia, cerebral blood flow (CBF) and intra-cranial pressure (ICP) were least with sevoflurane.

Propofol is the most commonly used intravenous anesthetic. It has many theoretical advantages by reducing cerebral blood volume (CBV) and ICP and preserving both autoregulation and vascular reactivity. Neurosurgical patients anaesthetized with propofol were found to have lower ICP and higher CPP than those anaesthetized with isoflurane or sevoflurane.

The well known pharmacodynamic advantages of intravenous anesthetics may give this group of drugs superior cerebral effects when compared with inhalation anesthetics.

Detailed Description

The aim of this study is to evaluate the cerebral haemodaynamics and global cerebral oxygenation as well as the systemic haemodaynamic changes using dexmedetomidine, propofol and fentanyl as total intravenous anaesthestics (TIVA) in comparison with sevoflurane - fentanyl anesthesia in brain tumor resection.

Indicators of global cerebral oxygenation and haemodynamics will be calculated using jugular bulb and peripheral arterial blood sampling.

* Induction: propofol, 1.5 - 2 mg/kg.

* Muscle Relaxants: atracurium, 0.5 mg/kg with induction and 0.1 mg/kg/20min. for maintenance.

* Cannulation: Arterial cannula: under complete aseptic conditions 20G cannula was inserted into the radial artery of non dominant hand after performing modified Allen's test and local infiltration of 0.5ml xylocaine 2%.

Central venous catheter: A suitable central venous catheter will be inserted into Rt subclavian vein under complete aseptic technique, its correct position will be confirmed with chest X-Ray.

Jugular bulb catheterization: Under strict sterile technique the right internal jugular vein will be cannulated in a retrograde technique with confirmation of the catheter tip position using X-Ray (C- arm). Puncture site will be at the level of cricoid cartilage behind the anterior border of the sternocleido-mastoid muscle.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • American Society of Anesthesiologists physical status III or IV.
  • Patients scheduled for elective brain tumor resection
Exclusion Criteria
  • Morbid obese patients.
  • Severe or uncompensated cardiovascular diseases.
  • Severe or uncompensated renal diseases.
  • Severe or uncompensated hepatic diseases.
  • Severe or uncompensated endocrinal diseases.
  • Pregnancy.
  • Postpartum or lactating females.
  • Allergy to one of the agents used.
  • Severely altered consciousness level.
  • Sitting position during surgery.
  • Prone position during surgery,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Propofol-Dexmedetomidine groupPropofol-Dexmedetomidine groupthis group is planned to receive intravenous anaesthesia only
Sevoflurane groupSevoflurane groupthis group is planned to receive sevoflurane/fentanyl anaesthesia
Primary Outcome Measures
NameTimeMethod
Arterio-Jugular oxygen content differenceimmediately after cannulation (arterial and jugular), every 30 min during surgery and after complete closure of the scalp
Estimated cerebral metabolic rate for O2 (eCMRO2)immediately after cannulation (arterial and jugular), every 30 min during surgery and after complete closure of the scalp

eCMRO2=Ca- jO2 x(PaCO2 ∕ 100) Where Ca jO2 is arterio-jugular O2 content difference. PaCO2 is arterial CO2 tension

Cerebral Extraction Rate of O2 (CEO2)immediately after cannulation (arterial and jugular), every 30 min during surgery and after complete closure of the scalp.

Calculated as the differences between arterial and jugular bulb O2 saturations, CEO2 = SaO2 - SjvO2

Cerebral Blood Flow equivalent (CBFe)immediately after cannulation (arterial and jugular), every 30 min during surgery and after complete closure of the scalp

Which is an index of flow metabolism relationship, calculated as a reciprocal of arterio-jugular O2 content difference. CBFe = 1 ∕CaO2-CjvO.

Secondary Outcome Measures
NameTimeMethod
Time for first analgesic request from extubationfor 6 hours after surgery
Total analgesics receivedfor 24 hours after surgery
Heart ratewill be monitored continiously and recorded immediately after intubation, every 30 min during surgery and immediately after closure of the scalp
Blood pressurewill be monitored continiously and recorded immediately after intubation, every 30 min during surgery and immediately after closure of the scalp
End-tidal carbon dioxide tensionwill be monitored continiously and recorded immediately after intubation, every 30 min during surgery and immediately after closure of the scalp
Central venous pressurewill be monitored continiously and recorded immediately after intubation, every 30 min during surgery and immediately after closure of the scalp
Postoperative level of sedationevery 5 min for 60 min, after extubation

all patients will be evaluated using Ramsay sedation scale

Intensive care unit stayfor 10 days after surgery
© Copyright 2025. All Rights Reserved by MedPath